Overview

A Study of LY2090314 and Chemotherapy in Participants With Metastatic Pancreatic Cancer

Status:
Terminated
Trial end date:
2015-06-01
Target enrollment:
Participant gender:
Summary
Purpose of this phase I/II study is to test how well LY2090314 works in combination with different chemotherapies in treating participants with metastatic pancreatic cancer.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Eli Lilly and Company
Collaborator:
Mayo Clinic
Treatments:
Albumin-Bound Paclitaxel
Fluorouracil
Gemcitabine
Leucovorin
Oxaliplatin
Paclitaxel